Skip to content

BRUPHARMA

Active Public limited companyfounded 1997active for 29 yearsMargaretha van Oostenrijkplein 3, 1083 GanshorenKBO/BCE: BE 0460.143.947 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 29 filings since 1997
peak of €503,792 in 2025
€503,792▲ 9.2%
lowest -€60,590 in 2015
€31,889▲ 33.4%
peak of -€14,388 in 2025
-€14,388▲ €31,889
€886,091▲ 14.5%
peak of 8 FTE in 2008
5.3 FTE▲ 8.2%
Board4 names since 2011
1 director
Owners
99%
Documentsfilings and deeds
18-11-2026110 days late
2025abbreviated format
Result from €23,906 to €31,889Staff from 4.9 FTE to 5.3 FTEEquity from -€46,276 to -€14,388Cash from €43,195 to €149,601

Key points

from the 2025 annual accounts

Equity

-€46,276
201920202021202220232024

Debts exceed assets in financial year 2024.

Turnover

≈ €1.6m estimated

The abbreviated format states no turnover.

Debts

€886,091 102% of the balance sheet
After one year 18%Within one year 82%

Of this, €725,556 falls due within a year.

Staff

5.3 FTE from 8 in 2008

Between 2008 and 2025, the number of full-time equivalents fell by 34%.

Filings

29 annual accounts 110 days
AprilJune31 JulyOctober200020102020

Latest accounts filed late: after the legal deadline.

Position in the sector

-€14,388

Less equity than 90% of companies in retail trade. The sector median is €314,797, over 13,292 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,454 companies had the same profile as BRUPHARMA has now. Each dot stands for 4 companies, two years later.

92.2%
were still trading
4.9%
stopped another way
2.5%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a profit under 5% of the balance sheet

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,454 companies, not a prediction for BRUPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 11-12-2023
  • 99%score equity €459,740 (2025) · annual accounts 30-06-2025 of
Board & ownership

Recent changes

changes role from director to sole director Gazette deed
1 director appointed, 3 resignations (managing director), and (managing director) resign · appointed as managing director · General meeting of 02-01-2019 · Gazette deed
4 directors reappointed (managing director), (managing director), and · and act as permanent representatives · General meeting of 28/09/17 · Gazette deed
Amendment of the articles General meeting of 26-12-2011 · Gazette deed
All 41 events

Comparable companies

same main activity, similar in size and age
Company
BRUPHARMA Ganshoren €871,703 €503,792 -1.7% 5.3
PHARMACIE DE CHASTRE Chastre €922,129 €496,114 68.4% 5
PHARMATHUS Aubange €845,919 €612,062 30.9% 5.4
G.L.PHARMA Eghezée €880,117 €591,990 61.9% 5.7
PHARMACIE DE LA VERTE FEUILLE Tournai €831,504 €575,605 11.3% 4.7
APOTHEEK WOUTERS KOERSEL Beringen €758,333 €560,298 30.1% 5.7
PHARMACIE CHRISTIANE NOEL Tenneville €959,070 €528,616 61.2% 4.5

These companies have the same main activity as BRUPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €758,000 and €959,000, founded between 1992 and 1999.

Official details

Source: KBO
Status
Active since 03-03-1997Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.005.101.8461083 Ganshoren, since 27-08-1997
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2024

€727,515▼ 2.7%
Employeeson 31-12-2024
6▲ 20.0%
Filing
2025 annual accounts filed on 18-11-2026
Financials

Insights on BRUPHARMA

BRUPHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €345,063 in 2006 to €503,792 in 2025.

The balance sheet grew most from 2019 to 2020 through fixed assets, financed with long-term debt.

holds 99% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BRUPHARMA

What is the company number of BRUPHARMA?
The company number of BRUPHARMA is 0460.143.947. The VAT number is the same number with BE in front: BE 0460.143.947.
Where is BRUPHARMA based?
The registered office is at Margaretha van Oostenrijkplein 3, 1083 Ganshoren.Company details
What does BRUPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of BRUPHARMA?
BRUPHARMA is a public limited company (NV).
When was BRUPHARMA founded?
BRUPHARMA was founded on 03-03-1997.
Is BRUPHARMA still active?
Yes, BRUPHARMA is an active enterprise in the KBO register.
How many employees does BRUPHARMA have?
BRUPHARMA had an average of 4.9 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does BRUPHARMA fall under?
In its 2025 annual accounts, BRUPHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of BRUPHARMA?
The turnover in financial year 2024 is about €1.6m. This figure is estimated from the gross margin of €461,304 and 42 comparable companies (NACE 477). It probably lies between €1.3m and €2.2m.
Is BRUPHARMA profitable?
In financial year 2024, BRUPHARMA made a profit of €23,906.
Where can I find the annual accounts of BRUPHARMA?
BRUPHARMA filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BRUPHARMA due?
BRUPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.